Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/127765
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Increased neurotransmitter release at the neuromuscular junction in a mouse model of polyglutamine disease

AutorRozas, José Luis CSIC; Gómez-Sánchez, L.; Tomás-Zapico, Cristina CSIC ORCID; Lucas, José Javier CSIC ORCID; Fernández-Chacón, Rafael CSIC ORCID
Fecha de publicación19-ene-2011
EditorSociety for Neuroscience
CitaciónJournal of Neuroscience 31: 1106- 1113 (2011)
ResumenIn Huntington's disease (HD), the expansion of polyglutamine (polyQ) repeats at the N terminus of the ubiquitous protein huntingtin (htt) leads to neurodegeneration in specific brain areas. Neurons degenerating in HD develop synaptic dysfunctions. However, it is unknown whether mutant htt impacts synaptic function in general. To investigate that, we have focused on the nerve terminals of motor neurons that typically do not degenerate in HD. Here, we have studied synaptic transmission at the neuromuscular junction of transgenic mice expressing a mutant form of htt (R6/1 mice).Wehave found that the size and frequency of miniature endplate potentials are similar in R6/1 and control mice. In contrast, the amplitude of evoked endplate potentials in R6/1 mice is increased compared to controls. Consistent with a presynaptic increase of release probability, synaptic depression under high-frequency stimulation is higher in R6/1 mice. In addition, no changes were detected in the size and dynamics of the recycling synaptic vesicle pool. Moreover, we have found increased amounts of the synaptic vesicle proteins synaptobrevin 1,2/VAMP 1,2 and cysteine string protein-α, and the SNARE protein SNAP-25, concomitant with normal levels of other synaptic vesicle markers. Our results reveal that the transgenic expression of a mutant form of htt leads to an unexpected gain of synaptic function. That phenotype is likely not secondary to neurodegeneration and might be due to a primary deregulation in synaptic protein levels. Our findings could be relevant to understand synaptic toxic effects of proteins with abnormal polyQ repeats. Copyright©2011 the authors.
URIhttp://hdl.handle.net/10261/127765
DOI10.1523/JNEUROSCI.2011-10.2011
Identificadoresdoi: 10.1523/JNEUROSCI.2011-10.2011
issn: 0270-6474
Aparece en las colecciones: (CBM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
LucasJJ_IncreasedNeurotransmitter.pdf1,51 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

23
checked on 04-mar-2024

SCOPUSTM   
Citations

42
checked on 25-mar-2024

WEB OF SCIENCETM
Citations

38
checked on 26-feb-2024

Page view(s)

232
checked on 28-mar-2024

Download(s)

163
checked on 28-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.